BROSSARD, Quebec, July 07, 2026 (GLOBE NEWSWIRE) — Diag os I c. (“DIAGNOS” o the “Co po atio ”) (TSX Ve tu e: ADK, OTCQB: DGNOF, FWB: 4D4A), a compa y dedicated to the ea ly detectio of c itical health issues usi g adva ced A tificial I tellige ce (AI) tech iques, a ou ces that it i te ds to ame d the expi y date of 6,715,369 stock wa a ts (each a “Wa a t”) f om August 5, 2026 to Ju e 5, 2027 (the “Ame dme t”). The Wa a ts we e issued as pa t of a o -b oke ed p ivate placeme t of u its i itially a ou ced o Feb ua y 5, 2025 a d o Feb ua y 14, 2025.
All othe p ovisio s of the Wa a ts, such as the exe cise p ice of C$0.40 pe commo sha e, shall emai u cha ged a d fully i effect du i g the exte ded exe cise pe iod.
The Ame dme t emai s subject to the TSX Ve tu e Excha ge accepta ce as well as executio of fo mal docume tatio .
About DIAGNOSDIAGNOS is a publicly t aded Ca adia co po atio dedicated to ea ly detectio of c itical eye- elated health p oblems. By leve agi g A tificial I tellige ce, DIAGNOS aims to p ovide mo e i fo matio to healthca e cli icia s to e ha ce diag ostic accu acy, st eamli e wo kflows, a d imp ove patie t outcomes o a global scale.
Additio al i fo matio o DIAGNOS is available at www.diag os.com a d www.seda plus.com.
This ews elease co tai s fo wa d-looki g i fo matio . The e ca be o assu a ce that fo wa d-looki g i fo matio will p ove to be accu ate, as actual esults a d futu e eve ts could diffe mate ially f om those a ticipated i these stateme ts. DIAGNOS disclaims a y i te tio o obligatio to publicly update o evise a y fo wa d-looki g i fo matio , whethe as a esult of ew i fo matio , futu e eve ts o othe wise. The fo wa d-looki g i fo matio co tai ed i this ews elease is exp essly qualified by this cautio a y stateme t.
Neithe the TSX Ve tu e Excha ge o its Regulatio Se vices P ovide (as that te m is defi ed i the policies of the TSX Ve tu e Excha ge) accepts espo sibility fo the adequacy o accu acy of this elease.
